ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
-4.2%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$287M
AUM Growth
+$287M
(-19%)
Cap. Flow
-$53.8M
Cap. Flow
% of AUM
-18.75%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
165
New
32
Increased
12
Reduced
17
Closed
46
Top Buys
| 1 |
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
|
$7.23M |
| 2 |
DexCom
DXCM
|
$6.4M |
| 3 |
Tandem Diabetes Care
TNDM
|
$5.82M |
| 4 |
Envista
NVST
|
$5.12M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$4.77M |
Top Sells
| 1 |
Lantheus
LNTH
|
$12.8M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$8.8M |
| 3 |
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
|
$7.2M |
| 4 |
Immatics
IMTX
|
$6.32M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$6.19M |
Sector Composition
| 1 | Healthcare | 81.73% |
| 2 | Financials | 7.62% |
| 3 | Industrials | 1.25% |
| 4 | Technology | 0.86% |
| 5 | Communication Services | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Exact Sciences
EXAS
$9.33B
| – | – |
-44,000
| Closed | -$3.43M |
|
152
89bio
ETNB
$1.37B
| – | – |
-148,000
| Closed | -$1.93M |
|
153
ESSA Pharma
EPIX
$11.2M
| – | – |
-345,000
| Closed | -$4.9M |
|
154
Dyne Therapeutics
DYN
$1.92B
| – | – |
-166,636
| Closed | -$1.98M |
|
155
Cardiff Oncology
CRDF
$130M
| – | – |
-337,000
| Closed | -$2.03M |
|
156
Context Therapeutics
CNTX
$75.6M
| – | – |
-493,531
| Closed | -$1.31M |
|
|
CNTB
157
Connect Biopharma
CNTB
$111M
| – | – |
-175,000
| Closed | -$901K |
|
158
Cingulate
CING
$20M
| – | – |
-83,931
| Closed | -$232K |
|
159
Cerus
CERS
$251M
| – | – |
-465,000
| Closed | -$3.17M |
|
160
Celcuity
CELC
$2.3B
| – | – |
-145,000
| Closed | -$1.91M |
|
161
BridgeBio Pharma
BBIO
$9.91B
| – | – |
0
| – | – |
|
|
AVDL
162
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-440,589
| Closed | -$3.56M |
|
163
MoonLake Immunotherapeutics
MLTX
$3.78B
| – | – |
-250,000
| Closed | -$2.47M |
|
164
My Size
MYSZ
$3.88M
| – | – |
-416,589
| Closed | -$210K |
|
165
Alphatec Holdings
ATEC
$2.35B
| – | – |
-255,000
| Closed | -$2.92M |
|